Broadcom Stock Headlines 3 Cash Flow Picks Trading Below Fair Value

Euro area wage growth has eased to 2.44%, which helps cool inflation pressures and keeps central bank policy expectations more measured. When markets worry less about aggressive rate moves, investors tend to pay closer attention to company level fundamentals like cash flows and valuation gaps. That is where undervalued stocks based on cash flows can appeal. This article highlights three stocks that currently screen as undervalued on that basis.

The three stocks below are just a starting sample, and the full screen surfaced 807 more companies that also look undervalued on cash flows and come with their own compelling narratives that are not covered here. To go deeper into this idea, head straight into the Undervalued Stocks Based On Cash Flows screener to identify, analyze, and focus on the opportunities that best match your own approach.

Broadcom is a large digital infrastructure company that designs semiconductor devices and infrastructure software used in data centers, networking, storage and enterprise IT. This ties it closely to the screener theme through its cash-generative networking and storage silicon sold to hyperscalers and large enterprises. The business generates about US$47.8b in revenue from Semiconductor Solutions and about US$27.7b from Infrastructure Software, giving it two sizeable engines of cash flow. At roughly US$1.7t in market value, Broadcom is one of the largest companies linked to AI and data infrastructure.

Investors looking at Broadcom are really looking at whether cash flows from AI chips, networking gear and VMware based software can keep justifying its size while the stock trades at about an 11.5% discount to the Simply Wall St DCF estimate. Multi year AI chip financing deals and long term commitments from customers like Google, Meta, OpenAI and Anthropic help support cash flow visibility. However, heavy use of debt and concentrated hyperscaler exposure mean that any slowdown in AI spending or pricing pressure could hit sentiment quickly. The mix of high margins, strong free cash flow and real balance sheet and competition risks makes Broadcom a stock where understanding the cash flow story in detail matters.

Broadcom’s cash machine in AI chips, networking and VMware based software is huge, yet the stock still shows an 11.5% discount to the Simply Wall St DCF estimate. See how the DCF valuation analysis for Broadcom frames that gap and what it could be missing about those hyperscaler risks.

Build your own cash flow shortlist around Broadcom

Broadcom and the two other stocks in this list all came from a single screener, but the real value for you is in creating filters that match your own style. Use our flexible Screener to blend cash flows, valuation, quality and risk checks into your own watchlist, or jump straight into our curated Investing Ideas for ready made stock shortlists.

MercadoLibre runs a combined e commerce marketplace and fintech platform across Latin America, with Mercado Pago’s payment processing, cash management products and credit services creating recurring fee based cash flows that fit this screener’s cash flow focus. The company reports about US$35.2b of revenue from Internet Software & Services and has a market value near US$97.4b.

Investors may pay attention to MercadoLibre because Mercado Pago is turning payments, deposits and a fast growing US$16.4b credit book into fee based cash flows that can be valued in a detailed DCF model, while the stock trades below the Simply Wall St fair value estimate. Profit margins have compressed and free cash flow has occasionally dipped as the credit portfolio expands, and high debt without deposit funding adds risk if conditions tighten. Revenue in the region has been building, user engagement is rising and management is using AI tools and ecosystem perks to deepen monetization. The durability of the credit engine, including reserve coverage and loan yields, remains an important factor for investors to monitor over time.

MercadoLibre’s accelerating payments and credit engine is easy to see, yet many investors may miss what the full cash flow picture implies for risk. Go straight to the DCF valuation analysis for MercadoLibre to see what the current pricing might be hinting at but not fully revealing

Merck is a large healthcare company best known for its human health pharmaceuticals business, where oncology and vaccine franchises such as Keytruda and Gardasil generate substantial recurring cash flows that underpins its fit in an undervalued cash flow screener. Human health pharmaceuticals bring in about US$59.6b of the company’s roughly US$66.6b in revenue, with the remaining slice coming from a sizeable animal health division and other revenue. Merck’s market value is about US$367.6b.

Investors looking at Merck today are really weighing a powerful cash engine in oncology and vaccines against the challenge of replacing Keytruda once exclusivity ends. The company’s tripled late stage pipeline, deeper ties with Moderna on cancer vaccines and more than 20 planned new products indicate a potentially long runway if execution stays on track. At the same time, a sharp hit to recent profit margins, high debt and a dividend that is not well covered by current earnings mean the cash flow story is not guaranteed. For value focused investors, the key consideration is whether the sizable discount to a cash flow based fair value compensates for those risks and the patent cliff that still lies ahead.

Merck’s cash engine in oncology and vaccines is powerful. However, the real story lies in how that strength lines up against the patent cliff and balance sheet pressure. Read the analysis report for Merck to see what the current market might be missing

Seeking Fresh Alternatives Before Others Catch On

New ideas can move from quiet to breakout quickly, and the best entry windows often close while others hesitate. Review these fresh stock shortlists before momentum changes and consider whether they fit your strategy.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com